Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

PROTAC Bcl-2 degrader-1 is a proteolysis-targeting chimera (PROTAC) composed of a Bcl-2 inhibitor conjugated to the cereblon (CRBN) inhibitor pomalidomide (Item No. 19877) via a PEG linker.1 It induces the degradation of Bcl-2 in HeLa cells with a half-maximal degradation concentration (DC50) value of 3 µM. PROTAC Bcl-2 degrader-1 induces selective degradation of Bcl-2 over myeloid cell leukemia-1 (Mcl-1), Bcl-xL, murine double minute 2 (MDM2), and tubulin in HeLa cells when used at a concentration of 10 µM.
WARNING This product is not for human or veterinary use.
1. Proteolysis targeting chimeras for the selective degradation of Mcl-